AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 103 filers reported holding AMYLYX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $287,280 | -85.0% | 151,200 | -77.5% | 0.00% | -86.2% |
| Q1 2024 | $1,910,752 | -11.7% | 672,800 | +357.7% | 0.03% | 0.0% |
| Q4 2023 | $2,163,840 | -77.9% | 147,000 | -72.6% | 0.03% | -80.8% |
| Q3 2023 | $9,807,861 | -42.2% | 535,656 | -31.9% | 0.15% | -49.7% |
| Q2 2023 | $16,969,119 | +27.1% | 786,700 | +72.9% | 0.30% | +16.3% |
| Q1 2023 | $13,349,700 | +30.7% | 455,000 | +25.4% | 0.26% | +83.0% |
| Q3 2022 | $10,213,000 | +78.4% | 362,847 | +22.1% | 0.14% | +80.8% |
| Q2 2022 | $5,725,000 | +199.4% | 297,251 | +99.8% | 0.08% | +239.1% |
| Q1 2022 | $1,912,000 | – | 148,767 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpha Wave Global, LP | 853,262 | $18,404,861 | 12.06% |
| Stonepine Capital Management, LLC | 1,121,028 | $24,180,574 | 8.72% |
| GREAT POINT PARTNERS LLC | 968,795 | $20,896,908 | 4.09% |
| Ghost Tree Capital, LLC | 550,000 | $11,863,500 | 3.92% |
| Perceptive Advisors | 4,873,919 | $105,130,433 | 3.04% |
| Altium Capital Management LP | 185,000 | $3,990,450 | 3.02% |
| Boxer Capital, LLC | 2,084,000 | $44,952 | 2.08% |
| SECTORAL ASSET MANAGEMENT INC | 387,310 | $8,354,277 | 1.39% |
| AlphaCentric Advisors LLC | 108,000 | $2,329,560 | 1.29% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 680,035 | $14,668,355 | 0.80% |